PURPOSE: Fatigue affects most chemotherapy recipients, who commonly experience it as distressing. Previous publications showed that cancer patients frequently lacked information and education regarding fatigue; and while most engaged in self-care activities, it remained unclear why they chose specific activities or how effective those were. We explored cancer chemotherapy recipients' current perspectives regarding fatigue, with particular attention to related communication with health professionals, self-care activities, and perceived effectiveness of these measures. This study was part of a larger project that explored patients' symptom experiences during chemotherapy over three months. METHOD: In this qualitative study, 19 patients with lymphomas, breast, lung or colorectal cancer participated concurrently with treatment at a Swiss tertiary care hospital's oncology outpatient clinic. Data on patients' fatigue experiences were collected via individual interviews following their third cycle of chemotherapy. Grounded Theory methodology guided data analysis. RESULTS: At the start of their chemotherapy, health professionals informed patients that common side effects included fatigue. While all participants experienced different dimensions of fatigue, then, all were willing to endure it for the sake of an expected improvement in their conditions. Individuals' fatigue experiences depended largely on their particular life and illness circumstances. Most engaged in fatigue-related self-care activities and managed the symptom on their own. Communication with or input from health professionals was virtually absent during chemotherapy. CONCLUSIONS: Adequate and systematic information regarding fatigue and related self-care strategies need to be implemented at the beginning of chemotherapy, along with continuous assessment and individual guidance of patients throughout their treatment. Copyright Â
PURPOSE:Fatigue affects most chemotherapy recipients, who commonly experience it as distressing. Previous publications showed that cancerpatients frequently lacked information and education regarding fatigue; and while most engaged in self-care activities, it remained unclear why they chose specific activities or how effective those were. We explored cancer chemotherapy recipients' current perspectives regarding fatigue, with particular attention to related communication with health professionals, self-care activities, and perceived effectiveness of these measures. This study was part of a larger project that explored patients' symptom experiences during chemotherapy over three months. METHOD: In this qualitative study, 19 patients with lymphomas, breast, lung or colorectal cancer participated concurrently with treatment at a Swiss tertiary care hospital's oncology outpatient clinic. Data on patients' fatigue experiences were collected via individual interviews following their third cycle of chemotherapy. Grounded Theory methodology guided data analysis. RESULTS: At the start of their chemotherapy, health professionals informed patients that common side effects included fatigue. While all participants experienced different dimensions of fatigue, then, all were willing to endure it for the sake of an expected improvement in their conditions. Individuals' fatigue experiences depended largely on their particular life and illness circumstances. Most engaged in fatigue-related self-care activities and managed the symptom on their own. Communication with or input from health professionals was virtually absent during chemotherapy. CONCLUSIONS: Adequate and systematic information regarding fatigue and related self-care strategies need to be implemented at the beginning of chemotherapy, along with continuous assessment and individual guidance of patients throughout their treatment. Copyright Â
Authors: Michele Cristina Miyauti da Silva; Luís Carlos Lopes; Lucila Castanheira Nascimento; Regina Aparecida Garcia de Lima Journal: Rev Lat Am Enfermagem Date: 2016-08-29
Authors: Roma Maguire; Patricia A Fox; Lisa McCann; Christine Miaskowski; Grigorios Kotronoulas; Morven Miller; Eileen Furlong; Emma Ream; Jo Armes; Elisabeth Patiraki; Alexander Gaiger; Geir V Berg; Adrian Flowerday; Peter Donnan; Paul McCrone; Kathi Apostolidis; Jenny Harris; Stylianos Katsaragakis; Alison R Buick; Nora Kearney Journal: BMJ Open Date: 2017-06-06 Impact factor: 2.692
Authors: Ann Langius-Eklöf; Marie-Therése Crafoord; Mats Christiansen; Maria Fjell; Kay Sundberg Journal: BMC Cancer Date: 2017-07-04 Impact factor: 4.430